Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INT131 Besylate vs Pioglitazone in Type 2 Diabetes
NCT00631007Phase 2Completed
- Sponsor
- InteKrin Therapeutics, Inc.
- Start
- Feb 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of INT131 in type 2 diabetes mellitus (T2DM), sponsored by InteKrin Therapeutics, Inc.. Started Feb 2008; status: completed.
02
Drugs
INT131
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00631007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631007.